$NVRO NEVRO CORP Insider Trading
Get free email notifications about insider trading in NEVRO CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NEVRO CORP. Insider overview, share value development, latest insider transactions and email notifications about new events in NEVRO CORP for free.
CIK Number: 0001444380
IRS Number: 562568057
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Trading Symbol: NVRO
Company Address: 1800 BRIDGE PARKWAY REDWOOD CITY 94065
Phone number: 650-251-0005
Market Capitalization: $2.71B
Prev close: $93.33
Average Daily Volume: 572,602
Days Low: $93.26
Year Low: $47.07
Year High: $106.93
NEVRO CORP Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 24 2021 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 179.03 | 6,445 | 1,153,837 | 231,277 | 237.7 K to 231.3 K (-2.71 %) |
Jun 22 2021 | NVRO | NEVRO CORP | GROSSMAN D KEITH | Chairman, President ... | Payment of Exercise | F | 160.45 | 4,874 | 782,033 | 118,838 | 123.7 K to 118.8 K (-3.94 %) |
Jun 16 2021 | NVRO | NEVRO CORP | MacLeod Roderick H. | Chief Financial Off ... | Payment of Exercise | F | 158.49 | 1,583 | 250,890 | 19,081 | 20.7 K to 19.1 K (-7.66 %) |
May 26 2021 | NVRO | NEVRO CORP | Vale Brad | Director | Grant | A | 0.00 | 1,167 | 0 | 8,198 | 7 K to 8.2 K (+16.60 %) |
May 26 2021 | NVRO | NEVRO CORP | OBOYLE KEVIN C | Director | Grant | A | 0.00 | 1,167 | 0 | 10,918 | 9.8 K to 10.9 K (+11.97 %) |
May 26 2021 | NVRO | NEVRO CORP | WEATHERMAN ELIZABETH H | Director | Grant | A | 0.00 | 1,167 | 0 | 18,039 | 16.9 K to 18 K (+6.92 %) |
May 26 2021 | NVRO | NEVRO CORP | McCormick Shawn | Director | Grant | A | 0.00 | 1,167 | 0 | 8,457 | 7.3 K to 8.5 K (+16.01 %) |
May 26 2021 | NVRO | NEVRO CORP | McCormick Shawn | Director | Sell | S | 149.65 | 482 | 72,131 | 7,290 | 7.8 K to 7.3 K (-6.20 %) |
Apr 02 2021 | NVRO | NEVRO CORP | Fischer Frank M | Director | Grant | A | 0.00 | 120 | 0 | 39,651 | 39.5 K to 39.7 K (+0.30 %) |
Apr 02 2021 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Grant | A | 0.00 | 188 | 0 | 236,555 | 236.4 K to 236.6 K (+0.08 %) |
Apr 02 2021 | NVRO | NEVRO CORP | WEATHERMAN ELIZABETH H | Director | Grant | A | 0.00 | 147 | 0 | 16,872 | 16.7 K to 16.9 K (+0.88 %) |
Apr 02 2021 | NVRO | NEVRO CORP | WEATHERMAN ELIZABETH H | Director | Grant | A | 0.00 | 147 | 0 | 16,872 | 16.7 K to 16.9 K (+0.88 %) |
Mar 23 2021 | NVRO | NEVRO CORP | GROSSMAN D KEITH | Chairman, President ... | Payment of Exercise | F | 142.81 | 4,873 | 695,913 | 127,975 | 132.8 K to 128 K (-3.67 %) |
Mar 15 2021 | NVRO | NEVRO CORP | GROSSMAN D KEITH | Chairman, President ... | Grant | A | 0.00 | 20,953 | 0 | 132,848 | 111.9 K to 132.8 K (+18.73 %) |
Mar 12 2021 | NVRO | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Of ... | Option Exercise | M | 64.95 | 750 | 48,713 | 65,575 |